functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />
Another possible measure of intestinal permeability in<br />
the small bowel is the oral lactulose/mannitol challenge<br />
test (69). In this <strong>functional</strong> assay, a patient<br />
consumes a st<strong>and</strong>ard amount of a solution of mannitol,<br />
a sugar alcohol, <strong>and</strong> the disaccharide lactulose in a<br />
hyperosmolar solution. Individuals with increased gut<br />
permeability of the small bowel absorb more lactulose,<br />
which is not metabolized <strong>and</strong> excreted in the urine,<br />
than individuals whose mucosa is normal. Mannitol, on<br />
the other h<strong>and</strong>, is translocated at a relatively fixed rate<br />
in all individuals. Thus an increased ratio of lactulose<br />
to mannitol in the urine indicates enhanced intestinal<br />
permeability (69).<br />
Conducting a fecal calprotectin evaluation is another<br />
test for measuring intestinal inflammation (70,71).<br />
Calprotectin is a calcium-binding protein found in the<br />
following types of white blood cells: neutrophilic<br />
granulocytes, monocytes, <strong>and</strong> macrophages (70).<br />
Calprotectin resists metabolic degradation <strong>and</strong> can be<br />
measured in the feces. The fecal calprotectin test<br />
makes use of the fact that the release of calprotectin<br />
in the stool is associated with damage to the GI<br />
mucosa <strong>and</strong> increased inflammatory processes (71).<br />
b. Nutritional Influences in IBD<br />
A variety of nutrients have been found to be deficient<br />
in CD patients. Causes include malabsorption in the<br />
small intestine, increased nutrient need because of<br />
disease activity, low nutrient intake, nutrient loss due<br />
to chronic diarrhea or increased transit time or effect<br />
of medications. One study examining multiple nutrient<br />
deficiencies found 85% of 279 CD patients had<br />
deficiencies. Nutrients most frequently found deficient<br />
were iron, calcium, zinc, protein, Vt. B12 <strong>and</strong> folate<br />
(72).<br />
It has recently been suggested that certain protective<br />
nutrients <strong>and</strong> <strong>functional</strong> foods can provide protection of<br />
the gut mucosa from the CARD15/NOD2 related<br />
Th1-dominant inflammatory reactions (73). The amino<br />
acids glutamine <strong>and</strong> arginine, the essential<br />
micronutrients vitamin A, zinc, vitamin E <strong>and</strong> the B<br />
vitamin, pantothenic acid are among these protective<br />
nutrients. Evidence indicates that chronic H. pylori<br />
infection is associated with elevated oxidative stress in<br />
the intestinal mucosa, with increased levels of plasma<br />
lipid peroxides <strong>and</strong> other markers of free radical injury<br />
94<br />
2012<br />
(74). Therefore, supplementation with antioxidants,<br />
including ascorbic acid, tocopherol, <strong>and</strong> food flavinoids<br />
like quercetin (found in apples) <strong>and</strong> epicatechin<br />
gallate (from green tea), may be beneficial. Shapiro<br />
et al. (75) discusses the addition of polyphenols to<br />
artificial <strong>nutritional</strong> formulas to improve the outcome of<br />
patients with IBD. Five polyphenols in particular have<br />
shown in animal <strong>and</strong> human studies to have benefit in<br />
IBD by reducing inflammation associated with variations<br />
of the CARD15/NOD2 <strong>and</strong> SLC22A4/A5 genes:<br />
Boswellia, curcumin, epigallocatechin, quercetin, <strong>and</strong><br />
resveratrol (75-84). Prebiotics <strong>and</strong> probiotics are also<br />
important substances that support proper function of the<br />
GALT <strong>and</strong> lead to the repair phase of gastrointestinal<br />
restoration (73).<br />
Buddington <strong>and</strong> Weiher (85) proposed that, in<br />
managing <strong>functional</strong> gastrointestinal disorders, the GI<br />
system should be viewed as a flow system or ‚river‛.<br />
The GI tract is a complex ecological system that flows<br />
from top to bottom <strong>and</strong> requires nourishment to create<br />
the appropriate ‚ecology‛ within the small <strong>and</strong> large<br />
intestines (85).<br />
c. Putting It All Together With The Functional<br />
Medicine ‚4R TM ‛ GI Restoration Program<br />
There is a slow-moving but growing awareness that<br />
underst<strong>and</strong>ing the etiology at the genetic-molecularenvironmental<br />
level may be just as important if not<br />
more important than disease classification. ‚Functional<br />
Medicine‛ – an evidence based systems biology<br />
approach addresses this concept of underlying etiology<br />
<strong>and</strong> root cause solutions <strong>and</strong> is now being encouraged<br />
by the National Institutes of Health under the new<br />
program NIH Roadmap, a route to accelerate medical<br />
discoveries that will improve health (86). In essence,<br />
<strong>functional</strong> <strong>medicine</strong> assessment is concerned with<br />
underst<strong>and</strong>ing the antecedents, triggers, <strong>and</strong> mediators<br />
of dysfunction that give rise to molecular imbalances<br />
underlying the signs <strong>and</strong> symptoms of disease (6).<br />
The following is a brief adaptation of the ‚4R TM GI<br />
Restoration Program‛ that the Institute for Functional<br />
Medicine pioneered for the management of gut<br />
dysfunction <strong>and</strong> chronic disease. (6,87). It is a<br />
conceptual framework with which to target therapies<br />
aimed at improving GI function.